CoChat

Peroxisome proliferator-activated receptor γ (PPARγ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer

Open access
Van Ginderachter, Jo A., Meerschaut, Sofie, Liu, Yuanqing, Brys, Lea, De Groeve, Kurt, Hassanzadeh Ghassabeh, Gholamreza, Raes, Geert, De Baetselier, Patrick · 2006 · Blood
Cited by 110

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Tumors may escape from immune control by the induction of CD11b+Gr-1+ myeloid suppressor cells in the spleen. In this study, we demonstrate that this cell population can be subdivided into a CD11bhiGr-1intSSCloLy6GnegM-CSFRint immature monocytic fraction and a CD11bhi+Gr-1hiSSChiLy6GhiM-CSFRneg granulocytic fraction. Upon in vitro culture, the monocytic CD11b+Gr-1+ cell fraction is sufficient for cytotoxic T lymphocyte (CTL) suppression, which is linked to the gradual differentiation of these monocytic cells into mature F4/80+ CD68+ macrophages. These CTL-suppressive macrophages are alternatively activated (M2), as demonstrated by the expression of known and novel M2 signature genes. In search of M2-associated genes involved in the suppressive activity, it is shown that stimulation of peroxisome proliferator-activated receptor γ (PPARγ) and inhibition of phospholipase A2 (PLA2) activity cooperate to alleviate CTL suppression. Of importance, purified tumor-associated macrophages display a similar M2 phenotype and are suppressive for antitumor CTLs, via a mechanism that can be almost completely reversed by PPARγ ligands. Overall, our data identify PLA2 and especially PPARγ as new potential therapeutic targets to subvert macrophage-mediated CTL suppression in cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2005-09-3777

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 110

Metadata

Authors
Van Ginderachter, J. A., Meerschaut, S., Liu, Y., Brys, L., De Groeve, K., Hassanzadeh Ghassabeh, G., Raes, G., & De Baetselier, P.
Venue
Blood
Published
2006-07-15
Volume
108
Issue
2
Pages
525-535
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2140755781
Cited by
110
References
11
FWCI
3.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peroxisome proliferator-activated receptor γ (PPARγ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. https://app.cochat.ai/papers/10.1182/blood-2005-09-3777
The paper
Van Ginderachter, J. A., Meerschaut, S., Liu, Y., Brys, L., De Groeve, K., Hassanzadeh Ghassabeh, G., Raes, G., & De Baetselier, P. (2006). Peroxisome proliferator-activated receptor γ (PPARγ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood. https://doi.org/10.1182/blood-2005-09-3777

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.